SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-16-465217
Filing Date
2016-02-16
Accepted
2016-02-16 16:06:01
Documents
3
Group Members
JOSHUA WOLFELUX CAPITAL MANAGEMENT, LLCLUX VENTURE ASSOCIATES II, LLCLUX VENTURE PARTNERS II, L.P.LUX VENTURES II SIDECAR, L.P.PETER HEBERT

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d142912dsc13ga.htm SC 13G/A 113767
2 EX-2 d142912dex2.htm EX-2 805
3 EX-3 d142912dex3.htm EX-3 17237
  Complete submission text file 0001193125-16-465217.txt   133534
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Subject) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87984 | Film No.: 161428018
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 295 MADISON AVENUE, 24TH FLOOR NEW YORK NY 10017
Business Address 295 MADISON AVENUE, 24TH FLOOR NEW YORK NY 10017 646-475-4385
Lux Ventures II, L.P. (Filed by) CIK: 0001592755 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A